News | May 15, 2023
Medico Remedies to foray into ointment manufacturing segment
The facility will have a capacity to manufacture upto 3 million tubes monthly
The facility will have a capacity to manufacture upto 3 million tubes monthly
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Subscribe To Our Newsletter & Stay Updated
